Cargando…
Progress on Denosumab Use in Giant Cell Tumor of Bone: Dose and Duration of Therapy
SIMPLE SUMMARY: Giant cell tumor of bone (GCTB) is an aggressive non-cancerous bone tumor. Surgery remains the main treatment for GCTB. Denosumab has been approved for the treatment of advanced or inoperable GCTB. The short-term efficacy and safety of denosumab in inoperable patients have been demon...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739142/ https://www.ncbi.nlm.nih.gov/pubmed/36497239 http://dx.doi.org/10.3390/cancers14235758 |